Immune-Related Adverse Events: Pneumonitis.

Checkpoint inhibitors Diffuse alveolar damage Hypersensitivity pneumonitis Immune-related adverse event Nonspecific interstitial pneumonia Organizing pneumonia Pneumonitis Thoracic imaging

Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2020
Historique:
entrez: 18 4 2020
pubmed: 18 4 2020
medline: 2 7 2020
Statut: ppublish

Résumé

Checkpoint inhibitors are part of the family of immunotherapies and are increasingly being used in a wide variety of cancers. Immune-related adverse events pose a major challenge in the treatment of cancer patients. Pneumonitis is a rare immune-related adverse event that presents in distinct patterns. The goal of this chapter is to instruct readers on the incidence and clinical manifestations of pneumonitis and to offer guidance in the evaluation and treatment of patients with pneumonitis.

Identifiants

pubmed: 32301020
doi: 10.1007/978-3-030-41008-7_13
pmc: PMC7161534
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-269

Références

Clin Imaging. 2013 Jul-Aug;37(4):680-6
pubmed: 23313188
Sci Rep. 2017 Mar 08;7:44173
pubmed: 28272463
Nature. 2006 Feb 9;439(7077):682-7
pubmed: 16382236
Sci Transl Med. 2011 Nov 30;3(111):111ra120
pubmed: 22133721
N Engl J Med. 2017 Nov 16;377(20):1919-1929
pubmed: 28885881
Pediatr Allergy Immunol Pulmonol. 2010 Mar;23(1):9-14
pubmed: 22087431
J Allergy Clin Immunol. 1980 May;65(5):347-52
pubmed: 6246152
CA Cancer J Clin. 2016 Jul;66(4):271-89
pubmed: 27253694
J Immunother Cancer. 2015 Sep 15;3:39
pubmed: 26380086
J Exp Med. 2009 Aug 31;206(9):1853-62
pubmed: 19667061
JAMA Oncol. 2016 Oct 1;2(10):1346-1353
pubmed: 27367787
Nature. 2017 May 25;545(7655):495-499
pubmed: 28514441
Immunity. 1995 Nov;3(5):541-7
pubmed: 7584144
J Oncol Pharm Pract. 2019 Apr;25(3):551-557
pubmed: 29207939
J Exp Med. 1999 Jan 18;189(2):435-40
pubmed: 9892625
J Clin Oncol. 2015 Oct 1;33(28):3193-8
pubmed: 26282644
Respir Med. 1997 Mar;91(3):175-7
pubmed: 9135858
Immunol Rev. 2009 May;229(1):114-25
pubmed: 19426218
Intensive Care Med. 2015 Feb;41(2):222-30
pubmed: 25476984
Invest New Drugs. 2018 Aug;36(4):638-646
pubmed: 29159766
Annu Rev Immunol. 2008;26:677-704
pubmed: 18173375
Histopathology. 1999 May;34(5):470
pubmed: 10231423
J Clin Oncol. 2015 Jun 10;33(17):1889-94
pubmed: 25667295
Br J Radiol. 2012 Sep;85(1017):1226-35
pubmed: 22553298
Chest. 2017 Aug;152(2):271-281
pubmed: 28499515
J Clin Oncol. 2018 Jun 10;36(17):1714-1768
pubmed: 29442540
Am J Clin Oncol. 2016 Feb;39(1):98-106
pubmed: 26558876
Eur Respir J. 2001 Jan;17(1):122-32
pubmed: 11307741
Onco Targets Ther. 2016 Aug 12;9:5023-39
pubmed: 27574444
Br J Cancer. 2015 Mar 3;112(5):943-7
pubmed: 25647015
Nat Commun. 2017 Feb 06;8:14369
pubmed: 28165004
Korean J Intern Med. 1996 Jun;11(2):113-21
pubmed: 8854647
N Engl J Med. 2006 Sep 7;355(10):973-5
pubmed: 16908487
Ann Emerg Med. 2019 Jan;73(1):79-87
pubmed: 29880440
Clin Med Insights Circ Respir Pulm Med. 2016 Feb 29;9(Suppl 1):123-33
pubmed: 26949346
N Engl J Med. 2015 Jan 22;372(4):320-30
pubmed: 25399552
Immunity. 1994 Aug;1(5):405-13
pubmed: 7882171
Radiol Clin North Am. 1996 Jan;34(1):33-46
pubmed: 8539352
EMBO J. 1992 Nov;11(11):3887-95
pubmed: 1396582
Eur J Cancer. 2016 Feb;54:139-148
pubmed: 26765102
J Exp Med. 2000 Oct 2;192(7):1027-34
pubmed: 11015443
Lancet Oncol. 2017 Dec;18(12):e731-e741
pubmed: 29208439
Pulm Med. 2011;2011:531302
pubmed: 21637367
Br J Cancer. 2016 May 10;114(10):1084-9
pubmed: 27124339
Cancer Immunol Res. 2016 Mar;4(3):194-203
pubmed: 26787823
Eur Respir J. 2006 Aug;28(2):422-46
pubmed: 16880372
Am J Respir Crit Care Med. 2016 Jun 1;193(11):1281-91
pubmed: 26649486
Ann Transl Med. 2017 Sep;5(17):365
pubmed: 28936459
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
J Immunother Cancer. 2016 Nov 15;4:80
pubmed: 27895919
J Thorac Imaging. 1986 Jul;1(3):25-30
pubmed: 3298678
Crit Rev Clin Lab Sci. 2009;46(4):167-89
pubmed: 19650714
Am Rev Respir Dis. 1987 Mar;135(3):705-12
pubmed: 3826896
J Clin Oncol. 2012 Jun 10;30(17):e156-9
pubmed: 22547608
Ann N Y Acad Sci. 2011 Jan;1217:45-59
pubmed: 21276005
J Clin Oncol. 2005 Sep 1;23(25):6043-53
pubmed: 16087944
Annu Rev Pathol. 2011;6:147-63
pubmed: 20936936
Science. 1995 Nov 10;270(5238):985-8
pubmed: 7481803
Crit Care. 2015 May 15;19:228
pubmed: 25981598
BMC Med. 2016 May 05;14:73
pubmed: 27151159
Clin Cancer Res. 2016 Dec 15;22(24):6051-6060
pubmed: 27535979
Invest New Drugs. 2018 Aug;36(4):601-607
pubmed: 29075985
Cell. 2015 Apr 9;161(2):205-14
pubmed: 25860605
J Immunother Cancer. 2016 Dec 20;4:94
pubmed: 28031822
AJR Am J Roentgenol. 2011 Dec;197(6):W992-W1000
pubmed: 22109345
Chest. 1993 Apr;103(4):1202-9
pubmed: 8131466
Med Phys. 2017 Sep;44(9):4747-4757
pubmed: 28657201
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1048-56
pubmed: 25670540
Chest. 1992 Jul;102(1 Suppl):2S-6S
pubmed: 1623805
Thorax. 2000 Apr;55(4):318-28
pubmed: 10722773
N Engl J Med. 2015 Oct 22;373(17):1627-39
pubmed: 26412456
Cancer Immunol Immunother. 2018 Jan;67(1):127-134
pubmed: 28983773
Ann Oncol. 2012 Sep;23 Suppl 8:viii6-9
pubmed: 22918931
JAMA Oncol. 2016 Dec 1;2(12):1607-1616
pubmed: 27540850
Cancer Biother Radiopharm. 2011 Feb;26(1):1-64
pubmed: 21355777
J Exp Med. 1995 Aug 1;182(2):459-65
pubmed: 7543139
Intensive Care Med. 2012 Oct;38(10):1573-82
pubmed: 22926653
Chest. 1989 Nov;96(5):999-1004
pubmed: 2805873
Semin Immunol. 2004 Apr;16(2):81-8
pubmed: 15036231
J Immunother Cancer. 2018 Feb 12;6(1):14
pubmed: 29433571
Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304
pubmed: 11790668
Ann Oncol. 2015 Dec;26(12):2375-91
pubmed: 26371282
Radiology. 2008 Jan;246(1):288-97
pubmed: 18096541
Ann Oncol. 2018 Jan 1;29(1):250-255
pubmed: 29045547
J Thorac Oncol. 2018 Dec;13(12):1930-1939
pubmed: 30267842
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Nat Immunol. 2002 Jul;3(7):611-8
pubmed: 12087419
Thorax. 2011 Feb;66(2):144-50
pubmed: 21139119
Mol Cell Biol. 2005 Nov;25(21):9543-53
pubmed: 16227604
Eur Respir J. 1996 May;9(5):1055-62
pubmed: 8793469
N Engl J Med. 2017 Oct 5;377(14):1345-1356
pubmed: 28889792
J Immunother Cancer. 2017 Nov 21;5(1):95
pubmed: 29162153
Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4223-E4232
pubmed: 28484017
Radiology. 2009 Apr;251(1):271-9
pubmed: 19221055
Eur Respir Rev. 2014 Mar 1;23(131):40-54
pubmed: 24591661
Immunol Rev. 2010 Jul;236:219-42
pubmed: 20636820
Chest. 1999 Nov;116(5):1168-74
pubmed: 10559072
Eur Respir J. 2011 Aug;38(2):384-91
pubmed: 21273390
N Engl J Med. 2015 Jul 2;373(1):23-34
pubmed: 26027431
Ann Am Thorac Soc. 2017 Jun;14(6):844-850
pubmed: 28570160
Lancet Oncol. 2014 Jun;15(7):700-12
pubmed: 24831977
J Exp Med. 1996 Jun 1;183(6):2541-50
pubmed: 8676075
Cancer. 2018 Jan 15;124(2):271-277
pubmed: 28960263
Ann Am Thorac Soc. 2014 Jan;11(1):87-91
pubmed: 24460438
Cancer. 2018 May 1;124(9):2010-2017
pubmed: 29469949
Am J Respir Crit Care Med. 2015 Oct 15;192(8):974-82
pubmed: 26168322
Cancer Med. 2018 Aug;7(8):4115-4120
pubmed: 29797416
Annu Rev Immunol. 2006;24:65-97
pubmed: 16551244
Inflamm Bowel Dis. 2009 Jul;15(7):1090-100
pubmed: 19253307
N Engl J Med. 2015 Jun 25;372(26):2521-32
pubmed: 25891173
Thorax. 2008 Sep;63 Suppl 5:v1-58
pubmed: 18757459
Eur Respir J. 2009 Jan;33(1):68-76
pubmed: 18829672
Intern Med. 2002 Jan;41(1):26-9
pubmed: 11838586
J Clin Oncol. 2017 Mar;35(7):709-717
pubmed: 27646942
Nat Immunol. 2001 Mar;2(3):261-8
pubmed: 11224527
J Exp Med. 2009 Dec 21;206(13):3015-29
pubmed: 20008522
Ann Oncol. 2017 Oct 1;28(10):2377-2385
pubmed: 28945858
J Transl Med. 2009 May 20;7:35
pubmed: 19457253
Semin Respir Crit Care Med. 2001 Aug;22(4):423-34
pubmed: 16088690
Cancer Immunol Res. 2015 Oct;3(10):1185-92
pubmed: 26100356
N Engl J Med. 1985 Jan 17;312(3):152-8
pubmed: 3965933
Am J Respir Crit Care Med. 2008 Jun 15;177(12):1338-47
pubmed: 18388353
J Thorac Oncol. 2019 Mar;14(3):494-502
pubmed: 30503891
Exp Ther Med. 2015 Mar;9(3):829-834
pubmed: 25667636
Open Respir Med J. 2012;6:63-74
pubmed: 22896776
Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142
pubmed: 28881921

Auteurs

Linda Zhong (L)

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Mehmet Altan (M)

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Vickie R Shannon (VR)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ajay Sheshadri (A)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. asheshadri@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH